Trial Profile
A safety and pharmacokinetics study of benznidazole in pediatric patients 2 to 12 years of age
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2018
Price :
$35
*
At a glance
- Drugs Benznidazole (Primary)
- Indications Chagas disease
- Focus Adverse reactions; Pharmacodynamics
- 07 Sep 2017 New trial record